Sano Genetics

Lisa Conroy and I had the pleasure of representing Sano Genetics at the Lupus Research Alliance Breaking Through Gala last night. Earlier this year we announced our partnership with the Lupus Research Alliance and LifeBit to power the DREAM platform. (Read more here: https://lnkd.in/eif8NxPE) The phenomenal event was made better by the opportunity to spend the evening with our collaborators, including Nate Raine and Ingrid Saba. On the way home, we stopped to capture the Empire State Building in purple and red in honor of the LRA team and their incredible work to identify new treatments and potential cures for people living with Lupus.

🌟 From gene therapies for spinal muscular atrophy to AI-powered diagnostics for Alzheimer’s, precision medicine is paving the way for personalized neurological care. 🏔️ But challenges remain—access, equity, and privacy are just as important as technology. 📄 Our latest whitepaper explores how genetic insights and innovation are creating new possibilities for patients everywhere. Download today. 🔗 https://lnkd.in/eeND8r_q #precisionmedicine #neurology #genetics

What’s holding back precision neurology? 🧠 From the brain’s incredible complexity to the need for diverse genetic data and navigating ethical challenges, progress isn’t without hurdles. In our latest blog, we explore how tackling these obstacles can unlock better treatments for neurological disorders by: ✨ Building inclusive genetic databases 🔒 Safeguarding patient privacy and informed consent ⚖️ Breaking down barriers to equitable care 🔗 Read the full post here: https://lnkd.in/eD6nxV63 #PrecisionNeurology #Genetics #PrecisionMedicine

On The Genetics Podcast, Patrick recently chatted with Noam Baumatz, CEO of NOGA Therapeutics. Noam shared his journey to becoming a biotech founder, driven by the loss of his daughter to a rare genetic disorder. Through Noga Therapeutics, he’s pioneering gene therapies for rare diseases, focusing on innovative, targeted approaches for primary immunodeficiencies.🔬 Read a recap or listen to the full version of this incredible story here 👉 https://lnkd.in/e7V6AkY5 #RareDiseases #GeneTherapy #Genetics

What can isolated populations teach us about genetics? 🌍 In this week's episode of The Genetics Podcast, Dr. Jim Wilson, Professor of Human Genetics at the The University of Edinburgh, shared insights from his fascinating work studying the genetics of isolated populations. This research has already revealed: 👉 BRCA1 mutation affects one in 20 individuals in Orkney 👉 A cardiomyopathy variant is 4,700 times more common in Shetland than in the general population 👉 One in 40 Shetlanders carries a mutation linked to Batten disease These discoveries don’t just tell a story of ancestry—they highlight how isolated populations can simplify the study of inherited diseases, paving the way for advances in precision medicine. 💡 📖 Read a quick recap: https://lnkd.in/euWAT6qf 🎧 Listen to the podcast episode: https://pod.fo/e/2857c7 #Genomics #PrecisionMedicine

Episode 162 of #TheGeneticsPodcast is live! This week, Patrick Short is joined by Jim Flett Wilson FRSE, Professor of Human Genetics at The University of Edinburgh. Listen in to hear him discuss:     🏴󠁧󠁢󠁳󠁣󠁴󠁿 The Viking Genes project and how it’s led him to work with isolated communities from more than 25 Scottish islands 🧬 How rolling out genetic screening programs for these communities can significantly improve health outcomes and provide highly actionable insights 👑 Sequencing Prince William’s mitochondrial DNA  🎬 His IFTA-winning work with the Irish Traveller community And much more. Listen by following the link below 👇 or simply search “The Genetics Podcast” on your go-to podcast platform. 🎧 https://lnkd.in/eBGXsc84 📽️ https://lnkd.in/e98UafwM Please consider rating and reviewing us on your chosen podcast listening platform! #SanoGenetics #Genomics #Genetics #Sequencing 

Tell us what it’s like to live with GT and speed up research! We want to learn about how GT impacts you daily as well as your overall quality of life living with an ultra-rare bleeding disorder. It will only take 5-10 minutes to complete. Follow the link: https://lnkd.in/eNMiBcFB Hemab Therapeutics and Sano Genetics have launched a secure encrypted survey, to understand daily life with GT in ways most researchers and hematologists don’t understand. Traditionally researchers work in isolation from people who live with rare conditions, including GT. With the support of this community, we want to change this. #ultrararebleedingdisorders #plateletdisorders #healthcare #bleedingdisorders

🎧 On last week's episode of The Genetics Podcast, Patrick Short spoke with Michelle Teng, CEO and co-founder of Etcembly Ltd, to discuss her groundbreaking work at the crossroads of immunotherapy and machine learning. 🔬 Their conversation touched on fascinating advancements in immunotherapy cancer treatment, as well as Michelle's deeply personal drive to innovate in rare disease therapies. 👉 If you missed it, read a quick sumamry or listen in full here: https://lnkd.in/ebs43Jvg #Immunotherapy #MachineLearning #CancerResearch #Genetics #PrecisionMedicine

⚡ Neurology is at a turning point thanks to advances in precision medicine. From biomarker identification to genomic sequencing, new tools are allowing for earlier diagnoses, more tailored treatments, and a deeper understanding of complex neurological disorders. In our latest blog post, we explore: 🧠 The role of biomarkers in detecting diseases like Alzheimer’s early. 🧬 How genomic sequencing techniques like whole-exome sequencing are improving rare disease diagnosis. 💡The potential of epigenetics, pharmacogenomics, and gene therapy to shape the future of neurology. Read now 👉 https://lnkd.in/e2FrbFxj #Neurology #PrecisionMedicine #Genomics

Groundbreaking Phase 2 trial in Parkinson's Disease by Neuron23 innovating on multiple fronts: 🧬 Genetically targeted treatment: The trial focuses on identifying individuals with LRRK2-driven PD—a group that could make up as much as 30% of PD cases. 📱 Digital biomarkers developed by Roche Diagnostics will track symptoms via smartphone, providing insights beyond traditional clinic visits. Developed by Roche 🤝 Sano Genetics is proud to partner with Neuron23, QIAGEN, and Quest Diagnostics on this exciting trial, helping identify eligible participants, providing at-home DNA testing, matching to trial sites, and resources like genetic counseling and education.